Gufic BioSciences Ltd
Thu 13/03/2025,15:52:16 | NSE : GUFICBIO
Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
Open
₹ 330.00
Previous Close
₹ 329.95
Volume
53953
Mkt Cap ( Rs. Cr)
₹3278.07
High
₹ 336.70
Low
₹ 325.00
52 Week High
₹ 504.25
52 Week Low
₹ 277.65
Book Value Per Share
₹ 57.26
Dividend Yield
0.03
Face Value
₹ 1.00
What’s Your Call?
Collective community sentiment on Gufic BioSciences Ltd
Your Vote -
Buy
83.33%
Hold
12.50%
Sell
4.17%
83.33%
24 users have voted
Market Depth
How many stocks are available to buy or sell and at what prices.
Buy Order Quantity
100%
Sell Order Quantity
0%
Bid Price
Qty
326.90
66
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
66
Bid Price
Qty
0.00
0
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
0
Option Chain
Analyzes market sentiment, predicts Gufic BioSciences Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Gufic BioSciences Lt - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
-
Gufic BioSciences Lt - Analysts/Institutional Investor Meet/Con. Call Updates
-
Gufic BioSciences Lt - Analysts/Institutional Investor Meet/Con. Call Updates
-
Gufic BioSciences Lt - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Gufic BioSciences Lt - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
-
Gufic BioSciences Lt - Analysts/Institutional Investor Meet/Con. Call Updates
-
Gufic BioSciences Lt - Copy of Newspaper Publication
-
Gufic BioSciences Lt - Integrated Filing- Financial
-
Gufic BioSciences Lt - Integrated Filing (Financial)
-
Gufic BioSciences Lt - Investor Presentation
-
Gufic BioSciences Lt - Announcement under Regulation 30 (LODR)-Investor Presentation
-
Gufic BioSciences Lt - Results - Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Nine Months En
-
Gufic BioSciences Lt - Financial Result Updates
-
Gufic BioSciences Lt Q3 net profit down 13.21% at Rs 19.32 cr
-
Gufic BioSciences Lt - Outcome of Board Meeting
-
Gufic BioSciences Lt - Board Meeting Outcome for Meeting Held On Friday, February 14, 2025
-
Gufic BioSciences Lt - Analysts/Institutional Investor Meet/Con. Call Updates
-
Gufic BioSciences Lt - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Gufic BioSciences Lt - Board Meeting Intimation
-
Gufic BioSciences Lt - Board Meeting Intimation for Consideration And Approval Of, Inter Alia, Unaudited Financial Results (S
-
Gufic BioSciences Lt - Shareholders meeting
-
Gufic BioSciences Lt - Shareholder Meeting / Postal Ballot-Scrutinizer\s Report
-
Gufic BioSciences Lt - Analysts/Institutional Investor Meet/Con. Call Updates
-
Gufic BioSciences Lt - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Gufic BioSciences Lt - Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent
-
Gufic BioSciences Lt - General Updates
-
Gufic BioSciences Lt - Intimation Of Appointment Of Senior Management Personnel
-
Gufic BioSciences Lt - General Updates
-
Gufic BioSciences Lt - Intimation Of Grant Of Patent In Europe
-
Gufic BioSciences Lt has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2024
-
Gufic BioSciences Lt - Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent
-
Gufic BioSciences Lt - Update-Acquisition/Scheme/Sale/Disposal-XBRL
-
Gufic BioSciences Lt - General Updates
-
Gufic BioSciences Lt - Appointment Of Senior Management Personnel
-
Gufic BioSciences Lt - General Updates
-
Gufic BioSciences Lt - Announcement under Regulation 30 (LODR)-Updates on Acquisition
-
Gufic BioSciences Lt - Copy of Newspaper Publication
-
Gufic BioSciences Lt - Notice Of Shareholders Meetings-XBRL
-
Gufic BioSciences Lt - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
-
Gufic BioSciences Lt - Certificate under SEBI (Depositories and Participants) Regulations, 2018
-
Gufic BioSciences Lt - Shareholders meeting
-
Gufic BioSciences Lt - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
-
Gufic BioSciences Lt - General Updates
-
Gufic BioSciences Lt - Change In Name Of Registrar And Share Transfer Agent ('RTA') Of The Company \r\n\r\n
-
Gufic BioSciences Lt - Trading Window-XBRL
-
Gufic BioSciences Lt - Trading Window
-
Gufic BioSciences Lt - Updates
-
Gufic BioSciences Lt - Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent
-
Gufic BioSciences Lt - Outcome of Board Meeting
-
Gufic BioSciences Lt - Board Meeting Outcome for Meeting Held On Friday, December 27, 2024
-
Gufic receives NMPA China nod for Prilocaine API
-
Gufic BioSciences
-
Gufic Bio gets two patent certificates; stk gains
Key fundamentals
Evaluate the intrinsic value of Gufic BioSciences Ltd stock
Name | March-24 | March-23 | March-22 | March-21 | March-20 |
---|---|---|---|---|---|
Assets | 849.595 | 659.2153 | 330.3601 | 225.1873 | 241.9697 |
Liabilities | 849.595 | 659.2153 | 330.3601 | 225.1873 | 241.9697 |
Equity | 10.0278 | 9.6945 | 9.6945 | 9.6945 | 9.6945 |
Gross Profit | 145.8714 | 134.6513 | 145.7147 | 83.9195 | 52.1155 |
Net Profit | 86.1356 | 79.7048 | 95.8401 | 44.2316 | 22.6879 |
Cash From Operating Activities | -7.4571 | -26.5872 | 104.4442 | 89.0648 | 47.1018 |
NPM(%) | 10.67 | 11.54 | 12.3 | 9.06 | 5.98 |
Revenue | 806.6657 | 690.6208 | 779.1556 | 487.6987 | 378.8374 |
Expenses | 660.7943 | 555.9695 | 633.4409 | 403.7792 | 326.7219 |
ROE(%) | 15 | 13.88 | 16.69 | 7.7 | 3.95 |
Corporate Action
XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
---|---|---|---|---|
18 Sep 2024 | 0.1 | 10 | 0.03 | 321.05 |
24 Aug 2022 | 0.1 | 10 | 0.03 | 243.9 |
09 Sep 2021 | 0.1 | 10 | 0.03 | 190.7 |
03 Nov 2020 | 0.05 | 5 | 0.03 | 102.1 |
20 Sep 2019 | 0.05 | 5 | 0.03 | 59.7 |
0.05 | 5 | 0.03 | 145.55 | |
28 Aug 2017 | 0.05 | 5 | 0.03 | 66.25 |
19 Sep 2016 | 0.05 | 5 | 0.03 | 41.05 |
22 Sep 2015 | 0.05 | 5 | 0.03 | 14.05 |
18 Sep 2014 | 0.05 | 5 | 0.03 | 20.9 |
02 Sep 2013 | 0.05 | 5 | 0.03 | 5.55 |
16 Aug 2012 | 0.05 | 5 | 0.03 | 7.75 |
16 Sep 2011 | 0.05 | 5 | 0.03 | 6.05 |
20 Sep 2010 | 0.05 | 5 | 0.03 | 6.35 |
17 Sep 2009 | 0.05 | 5 | 0.03 | 6.35 |
11 Dec 2008 | 0.05 | 5 | 0.03 | 4.45 |
19 Mar 2008 | 0.05 | 5 | 0.03 | 9.45 |
20 Sep 2006 | 0.16 | 16 | 0.03 | 11.7 |
22 Sep 2005 | 0.22 | 22 | 0.03 | 29.75 |
Peers
Other companies within the same industry or sector that are comparable to Gufic BioSciences Ltd
Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
---|---|---|---|---|---|---|
Albert David Ltd | 808.20 | -1.14 | 11.41 | 186.74 | 1321.50 | 1.42 |
Lotus Eye Hospital and Institute Ltd | 57.06 | -0.77 | 237.75 | 680.45 | 14.01 | 0.88 |
Vaishali Pharma Ltd | 12.12 | -5.90 | 606.00 | 350.73 | 2.31 | 0.00 |
Astec Lifesciences Ltd | 653.90 | -5.55 | 0.00 | 641.61 | -239.30 | 0.00 |
Company Info
Central Finance Ltd. is a Bombay based company engaged in leasing, bill discounting, loan syndication, merchant banking/advisory services, investments, debt operations, portfolio management scheme, underwriting etc. Central Finance Securities Ltd. is the subsidiary of the company. The company has 100% stake in the subsidiary. 2000 - The Company name of changed to Gufic Biosciences Ltd. 2003 -Forays into vegetables market under the brand 'Gufic seeds'. 2004 -Gufic Biosciences eyes JV in biotech biz 2005 -Gufic Biosciences - Launch of new products 2007 -Gufic Biosciences Ltd has appointed Dr. M C Dhapalapur as Director of the Company on the Board of Directors of the Company with effect from August 01, 2007. 2008 - The Company has set up manufacturing facility for manufacture of Oncology Products. 2012 - The Board of Directors of the Company, inter alia, has recommended dividend @ 5% per share (i.e. Re. 0.05 per share). 2013 -Gufic Biosciences Ltd has irecommended dividend @ 5% per share (i.e. Re. 0.05 per share). 2014 - Ms. Hemal Deasi, Non- Independent Director has been appointed as an Additional Director. -Gufic Biosciences Ltd has recommended a dividend of Re. 0.05 per share on equity share of Rs. 1/- each.
Central Finance Ltd. is a Bombay based company engaged in leasing, bill discounting, loan syndication, merchant banking/advisory services, investments, debt operations, portfolio management scheme, underwriting etc. Central Finance Securities Ltd. is the subsidiary of the company. The company has 100% stake in the subsidiary. 2000 - The Company name of changed to Gufic Biosciences Ltd. 2003 -Forays into vegetables market under the brand 'Gufic seeds'. 2004 -Gufic Biosciences eyes JV in biotech biz 2005 -Gufic Biosciences - Launch of new products 2007 -Gufic Biosciences Ltd has appointed Dr. M C Dhapalapur as Director of the Company on the Board of Directors of the Company with effect from August 01, 2007. 2008 - The Company has set up manufacturing facility for manufacture of Oncology Products. 2012 - The Board of Directors of the Company, inter alia, has recommended dividend @ 5% per share (i.e. Re. 0.05 per share). 2013 -Gufic Biosciences Ltd has irecommended dividend @ 5% per share (i.e. Re. 0.05 per share). 2014 - Ms. Hemal Deasi, Non- Independent Director has been appointed as an Additional Director. -Gufic Biosciences Ltd has recommended a dividend of Re. 0.05 per share on equity share of Rs. 1/- each.
Read More
Parent Organisation
Gufic BioSciences Ltd.
Founded
23/07/1984
Managing Director
Mr.Jayesh P Choksi
NSE Symbol
GUFICBIOEQ
FAQ
The current price of Gufic BioSciences Ltd is ₹ 326.90.
The 52-week high for Gufic BioSciences Ltd is ₹ 336.70 and the 52-week low is ₹ 325.00.
The market capitalization of Gufic BioSciences Ltd is currently ₹ 3278.07. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Gufic BioSciences Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Gufic BioSciences Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Gufic BioSciences Ltd shares.
The CEO of Gufic BioSciences Ltd is Mr.Jayesh P Choksi, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.